 |
|
Comparison of Focal and Conventional Verteporfin Photodynamic Therapy for Chronic Central Serous Chorioretinopathy
Sung Rae Noh, Min Seok Kang, Kiyoung Kim, Eung Suk Kim, Seung-Young Yu
Korean J Ophthalmol. 2019;33(6):506-513. Published online 2019 Dec 5 DOI: https://doi.org/10.3341/kjo.2019.0065
|
|
Citations to this article as recorded by
 Central serous chorioretinopathy: Treatment
JongBeom Park, Kiyoung Kim, MinSeok Kang, EungSuk Kim, Seung-Young Yu
Taiwan Journal of Ophthalmology.2022; 12(4): 394. CrossRef Age-related macular degeneration masqueraders: From the obvious to the obscure
Manuel Paez-Escamilla, Mahima Jhingan, Denise S. Gallagher, Sumit Randhir Singh, Samantha Fraser-Bell, Jay Chhablani
Survey of Ophthalmology.2021; 66(2): 153. CrossRef Photodynamic Therapy with Verteporfin for Chronic Central Serous Chorioretinopathy: A Review of Data and Efficacy
Pierluigi Iacono, Stefano Da Pozzo, Monica Varano, Mariacristina Parravano
Pharmaceuticals.2020; 13(11): 349. CrossRef
|